Skip to main content
Back to Korea Investment Partners

Korea Investment Partners's Pharmaceutical Portfolio

Browse 10 Pharmaceutical companies funded by Korea Investment Partners. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
10
Total Funding in Pharmaceutical
$64.7M

Pharmaceutical Portfolio Companies (10)

Export
BiotechnologyManufacturingPharmaceutical

Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.

Seongnam, South Korea
December 2024
$13.6M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Plymouth Meeting, United States
September 2023
$5.0M
Series A

Founder Contacts

19,000+ verified contacts

Medical DevicePharmaceutical

LabInCube develops inCube materials capable of selective drug release, sustained release, and supporting complex raw materials.

Cheongju, South Korea
December 2025
Corporate Round

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical DevicePharmaceutical

Kangdesai Medical Technology is engaged in the development, transformation, and application of new cell therapy technologies.

Chengdu, China
September 2025
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.

Seoul, South Korea
August 2025
$3.6M
Series B

Founder Contacts

19,000+ verified contacts

PetPharmaceutical

Petpharma is an Operator of an e-commerce platform intended to provide veterinary medicines.

Seongnam, South Korea
February 2025
$4.5M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalPharmaceutical

Selta Square is an AI-based drug monitoring company that offers full-cycle drug monitoring solutions using AI technology.

Seoul, South Korea
January 2025
$6.4M
Series A

Founder Contacts

19,000+ verified contacts

AppsDietary SupplementsMobile AppsNutritionPharmaceutical

MyHerb Healthcare proivdes a specialized analysis for nutritional supplements.

Seoul, South Korea
January 2025
$2.9M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.

Seoul, South Korea
November 2024
$14.9M
Series C

Founder Contacts

19,000+ verified contacts

DentalE-CommerceMedical DevicePharmaceutical

Kangjian Miaomiao is an e-commerce platform that specializes in the production of full-category, customized oral and dental products.

Hangzhou, China
June 2024
$13.8M
Series B

Founder Contacts

19,000+ verified contacts

Explore Korea Investment Partners's Full Portfolio

View all companies funded by Korea Investment Partners across every industry and funding stage.

View Full Korea Investment Partners Portfolio